This presentation provides an up-to-date overview of the Australian National Lung Cancer Screening (NLCS) program, with a focus on its relevance to rural and regional practice. Lung cancer remains the leading cause of cancer-related mortality in Australia, largely due to late-stage diagnosis. The NLCS program represents a significant national initiative aimed at improving early detection through targeted low-dose CT screening of high-risk individuals.
The talk will outline the structure and implementation of the NLCS program, including referral pathways, screening intervals, and integration with primary care. Particular emphasis will be placed on eligibility criteria, including age, smoking history, and risk stratification, to support appropriate patient selection in clinical practice.
The presentation will also highlight the disproportionate burden of lung cancer in rural and regional populations, where incidence and mortality rates are higher compared to metropolitan areas, reflecting increased smoking prevalence, reduced access to healthcare services, and later-stage diagnosis. This disparity is further amplified in Aboriginal and Torres Strait Islander populations, who experience significantly higher rates of lung cancer and poorer outcomes. The implications of screening in these settings will be discussed, with a focus on the critical role of rural clinicians in early identification and follow-up. In addition, practical guidance will be provided on the assessment and management of pulmonary nodules detected through screening, emphasising risk stratification, appropriate surveillance, and referral pathways to ensure safe, timely, and effective care in resource-limited environments.